CF PHARAMTECH (02652) spent 1.9159 million Hong Kong dollars on May 22 to repurchase 100,000 shares.
Changfeng Pharmaceuticals (02652) announced that on May 22, 2026, it will spend HK$1.9159 million to repurchase 100,000 shares.
CF PHARMTECH (02652) announced on May 22, 2026 that it will spend 1.9159 million Hong Kong dollars to repurchase 100,000 shares.
Related Articles
SCHOLAR EDU (01769) recommends appointing Yung Cheng (Hong Kong) Certified Public Accountants as the new independent auditor.
LYGEND RESOURCE (02245) will distribute a final dividend of 0.6 yuan per share on June 18th.
Beijing eGOVA (300075.SZ) plans to invest in establishing a wholly-owned subsidiary to operate computing power services.
SCHOLAR EDU (01769) recommends appointing Yung Cheng (Hong Kong) Certified Public Accountants as the new independent auditor.
LYGEND RESOURCE (02245) will distribute a final dividend of 0.6 yuan per share on June 18th.
Beijing eGOVA (300075.SZ) plans to invest in establishing a wholly-owned subsidiary to operate computing power services.
